Abstract:Background: The previous works about safety evaluation for constructed bladder tissue specific adenovirus are poorly documented. Thus, we investigated the biodistribution and body toxicity of bladder specific oncolytic adenovirus Ad-PSCAE-UP-E1A (APU-E1A) and Ad-PSCAE-UP-E1A-AR (APU-E1A-AR), providing meaningful information prior to embarking on human clinical trials. Materials and Method Conditionally replicate recombinant adenovirus (CRADs) APU-E1A, APU-EIA-AR were constructed with bladder tissue specific Uroplakin (UP) promoter to induce the expression of Ad5E1A gene and E1A-AR fusing gene, and PSCAE was inserted at upstream of promoter to enhance the function of promoter. Based on the cytopathic and anti-tumor effect of bladder cancer, these CRADs were intratumorally injected into subcutaneous xenografts tumor in nude mice. We then determined the toxicity through general health and behavioral assessment, hepatic and hematological toxicity evaluation, macroscopic and microscopic postmortem analyses. The spread of the transgene E1A of adenovirus was detected with RT-PCR and Western blot. Virus replication and distribution were examined with APU-LUC administration and Luciferase Assay. Results: General assessment and body weight of the animals did not reveal any alteration in general behavior. The hematological alterations of groups which were injected with 5 x 10(8) pfu or higher dose (5 x 10(9) pfu) of APU-E1A and APU-E1A-AR showed no difference in comparison with PBS group, and only slight increased transaminases in contrast to PBS group at 5 10 9 pfu of APU-E1A and APU-E1A-AR were observed. E1A transgene did not disseminate to organs outside of xenograft tumor. Virus replication was not detected in other organs beside tumor according to Luciferase Assay. Conclusions: Our study showed that recombinant adenovirus APU-E1A-AR and APU-E1A appear safe with 5 x 10(7) pfu and 5 x 10(8) pfu intratumorally injection in mice, without any discernable effects on general health and behavior.

In vivo imaging system in detecting expression and distribution of replication-deficient adenovirus carrying luciferase in mice

The Biodistribution of Replication-Defective Simian Adenovirus 1 Vector in a Mouse Model

Induction of potent anti-tumor immunity by direct injection of Ad-LIGHT at the site of tumor inoculation.

Preliminary Experiment with Lung Cancer Cell Expressing Luciferase Reporter for in Vivo Molecular Imaging

Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging

Biodistribution and Safety Assessment of Bladder Cancer Specific Recombinant Oncolytic Adenovirus in Subcutaneous Xenografts Tumor Model in Nude Mice.

Establishment of Translational Luciferase-Based Cancer Models to Evaluate Antitumoral Therapies

Combined Bioluminescence and Fluorescence Imaging Visualizing Orthotopic Lung Adenocarcinoma Xenograft in Vivo.

Dynamic Distribution and Expression in Vivo of the Human Interferon Gamma Gene Delivered by Adenoviral Vector.

Non-Invasive Direct Visualization of Luciferase-Luciferin Emitted Light Producing True Images from an Orthotopic Lung Cancer Xenograft Model in Nude Mice Using an Ultra-sensitive Low-light Camera and Optics

Antitumor Effects Of Interleukin-18 Gene-Modified Hepatocyte Cell Line On Implanted Liver Carcinoma

Methodology of injection from portal vein the hepcidin gene-specific RNA interference adenovirus in mouse

RESEARCH ON DISSEMINATION OF RECOMBINANT ADENOVIRUS INTRA-TUMOR INJECTION IN HUMAN BODY

The Construction and Characterization of a Novel Adenovirus Vector of Artificial Microrna Targeting EGFR.

High Gene Expression of the Mutant Adenovirus Vector, Both in Vitro and in Vivo, with the Insertion of Integrin-Targeting Peptide into the Fiber

A bioluminescence reporter mouse strain for in vivo imaging of CD8+ T cell localization and function

Prolonged survival of mice with multiple liver metastases of human colon cancer by intravenous administration of replicable E1B-55K-deleted adenovirus with E1A expressed by CEA promoter

Novel method of generating prostate-specific Cre-LoxP gene switching via intraductal delivery of adenovirus

A rapid and efficient method for constructing murine tumor models with in vivo imaging

In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells

Longitudinal Monitoring of the Effects of Anti-Adenoviral Treatment Regimens in a Permissive In Vivo Model